جست‌وجوی استاد و پژوهشگر

Paul Cohenمشاهده پروفایل

استاد بالینی

• Gynaecological Cancers
• Ovarian Cancer
• Chemotherapy Resistance
• +۴ مورد دیگر

Paul Cohen is a Clinical Professor in the Division of Obstetrics and Gynaecology at the UWA Medical School, The University of Western Australia. He is also a Consultant at The Western Australian Gynaecological Cancer Service and a Clinical Research Fellow at the Harry Perkins Institute of Medical Research. His academic roles include editorial board memberships for International Journal of Gynecological Cancer and Scientific Reports . Education : Doctor of Medicine (MD), University of Auckland (2010), thesis: The Role of Oestrogen Receptor Beta in Ovarian Granulosa Cell Tumours BM BCh (Medicine), MA (Physiological Sciences), BA (Physiological Sciences), University of Oxford (1997–2001) Research Interests : Cohen’s work focuses on chemotherapy resistance in high-grade serous tubo-ovarian cancer, clinical trial design, and improving patient outcomes through innovations like the pathological chemotherapy response score (CRS). He leads national and international trials, including the Getting the MOST out of follow-up randomized controlled trial, and investigates genetic susceptibility (e.g., HELB gene in ovarian cancer). Recent Article Trends : His 2024–2025 publications emphasize genetic epidemiology, clinical trial implementation, and precision oncology, with contributions to understanding HPV-associated cancers and spatial transcriptomics in tumor microenvironments. Awards : 2024: UWA Medical School Excellence in Research (Mid-Career) 2022: UWA Excellence in Teaching Award 2021: Top Reviewer, International Journal of Gynecological Cancer Advising & Grants : Supervised 4 PhD, 3 MSc, and 3 MD students Principal Investigator for grants totaling over AUD 10M from MRFF, ANZGOG, and Cancer Research Trust Labs/Teams : Collaborates with ANZGOG, OTTA Consortium, and the Harry Perkins Institute of Medical Research. Leads the OVARIAN study and ADELE trial on endometrial cancer treatments.

• Evolutionary Genetics
• Molecular Adaptation
• Asexual Reproduction
• +۲ مورد دیگر

Nicolas Debortoli is an evolutionary geneticist focused on molecular adaptation mechanisms in asexual organisms, particularly bdelloid rotifers and freshwater invertebrates. His research examines genetic mixing, desiccation resistance, and environmental DNA applications for biodiversity monitoring. He has contributed significantly to understanding horizontal gene transfer in asexual species and urban ecosystem impacts on microinvertebrates. Research Interests: Debortoli investigates: (1) Evolutionary dynamics of asexual reproduction in bdelloid rotifers, (2) Genetic hybridization in clam lineages, (3) Environmental DNA metabarcoding for ecological assessment, and (4) Urbanization impacts on microinvertebrate communities. His work integrates genomics, field ecology, and computational biology. Publication Trends: His recent articles (2016-2024) demonstrate a shift from fundamental rotifer genetics toward applied environmental genomics, including SARS-CoV-2 surveillance validation and machine learning applications in hematology. Over 50% of his output addresses sustainable development goals related to aquatic ecosystems and biodiversity conservation.

• Public International Law
• International Organizations
• Air Law
• +۳ مورد دیگر

Georgios D. Kyriakopoulos is an Associate Professor of International Law at the School of Law, National and Kapodistrian University of Athens (NKUA), serving as Vice-Dean since 2009. He holds a BA from NKUA, DEA degrees in International Law and Political Science from Paris 2 University, and a PhD in International Law focusing on aviation security. His roles include Legal Adviser to the Greek Ministry of Defense, Visiting Professorships at McGill University and University of Nice, and membership in prestigious organizations like the European Society of International Law and International Law Association. He represents Greece at ICAO and UNCOPUOS and serves as Rapporteur for the Greek Ministry of Foreign Affairs' Scientific Council. Education: BA (Law, NKUA), DEA (International Law, Paris 2), DEA (Political Science, Paris 2), PhD (International Law, Paris 2). Research focuses on Public International Law, Air Law, Space Law, Telecommunications Law, and Maritime Law. Key interests include international organizations, aviation security, and space governance. He authored 3 monographs, 2 manuals, and numerous articles, including works on airspace regulation, space treaties, and unilateral state acts. Awards: Prix de thèse from French Society of Air and Space Law (1999). Advising and Grants: Supervises students in international law and contributes to policy-making via international bodies. His grants and projects include contributions to ICAO environmental policies and space law frameworks. Labs/Teams: Active in interdisciplinary research on international legal frameworks for emerging technologies, collaborating with institutions like McGill’s Air and Space Law Institute.

• Immunology
• Autoimmune diseases
• Genomics
• +۴ مورد دیگر

Professor Tony Kenna is an immunologist at Queensland University of Technology (QUT), leading research in autoimmune diseases like ankylosing spondylitis (AS) and scleroderma. He holds a PhD in Pharmacology from University College Dublin and is based in the School of Biomedical Sciences within QUT's Faculty of Health . His work integrates genomics, microbiome studies, and cellular immunology to identify therapeutic targets for immune-mediated diseases. He collaborates with the Centre for Immunology and Infection Control and Centre for Microbiome Research at QUT. Teaching focuses on undergraduate immunology, emphasizing problem-based learning. His editorial roles include journals like Clinical and Translational Immunology and Discovery Immunology . Professional memberships include the Australia and New Zealand Society for Immunology and the Australian Society for Medical Research. Research interests span genetic drivers of AS/scleroderma, microbiome-immune interactions, and translational therapies. Recent work highlights T-cell dysregulation in autoimmune conditions and biomarkers for disease progression. His lab explores therapeutic strategies like CAR-T cells and TCR-engineered regulatory T-cells for autoimmune diseases. Publications emphasize genomics-driven discoveries (e.g., HLA-B27 interactions, Runx3 deficiency in SKG mice), microbiome roles in AS pathogenesis, and long-term post-COVID-19 immunopathology. Collaborations bridge clinical and basic science to advance understanding of immune system dysregulation.

• Personalized Medicine
• Breast Cancer
• Cancer Staging
• +۴ مورد دیگر

Anja Brügmann serves as a Chief Physician ( Cheflæge ) at Aalborg University Hospital within The Faculty of Medicine, specifically in the Department of Pathology. Her work bridges clinical pathology practice with cutting-edge cancer research, focusing on precision medicine applications for cancer patients. Her research interests center around Personalized Medicine , Breast Cancer , Cancer Staging , Targeted Therapy , and Digital Pathology . Dr. Brügmann's work demonstrates a strong commitment to improving cancer diagnostics and treatment through molecular approaches, with particular emphasis on translating research findings into clinical practice. Her fingerprint analysis shows strong connections to Personalized Medicine (100%), Breast Cancer (80%), Cancer Staging (80%), and Targeted Therapy (80%). Analysis of her publication record reveals a consistent research trajectory focused on precision oncology, with recent work examining the clinical impact of precision medicine for late-stage cancer patients and the validation of digital pathology techniques. Her 2025 publication on longer survival with precision medicine in late-stage cancer represents the cutting edge of her current research focus. Dr. Brügmann has made significant contributions to Danish cancer research infrastructure, including participation in major biobank studies that support health research in Denmark. Her work with the Danish Scientific Committee of Pathology and the Danish Breast Cancer Cooperative Group (DBCG) demonstrates her leadership in establishing standardized protocols for cancer diagnostics. Her research methodology spans from molecular studies of cancer biology to large-scale clinical implementation projects, reflecting a comprehensive approach to advancing cancer care through pathology innovation.

• Machine Learning in Biomedicine
• Statistical Genetics
• Systems Genetics
• +۵ مورد دیگر

Dr. Francesco Paolo Casale serves as Principal Investigator in Machine Learning in Biomedicine at the Helmholtz Munich Institute AI for Health, part of Helmholtz Zentrum München and affiliated with Ludwig-Maximilians-Universität München's Biomedical Center. His research develops machine learning and statistical tools to analyze genetic cohorts with deep molecular and phenotypic data, addressing fundamental biomedical questions about disease mechanisms and progression. His academic foundation includes: PhD in Statistical Genetics from University of Cambridge & EMBL-EBI (2012-2016) M.Sc. in Physics of Complex Systems from Università di Napoli Federico II (2009-2012) B.Sc. in Physics from Università di Napoli Federico II (2009) Casale's research integrates machine learning, statistical inference, and systems genetics to develop scalable tools for genetic association studies, deep learning models for imaging genetics, and computational methods examining gene-environment interactions. His work emphasizes model robustness and interpretability while investigating molecular and cellular traits associated with disease severity. Current projects focus on rare variant analysis, aberrant gene expression prediction, and longitudinal omics data integration. His publication record shows a clear progression from foundational statistical genetics methods toward increasingly sophisticated integration of machine learning with multi-omics data. Recent work emphasizes practical biomedical applications including disease risk prediction through Mendelian randomization frameworks, advanced single-cell analysis techniques, and histopathology image classification. The research demonstrates consistent methodology development focused on scalability for large datasets while maintaining biological interpretability. Key recognitions include: Highly Recognized article in PloS Genetics Research Prize (2018) Microsoft Research New England Postdoctoral Fellowship (2017) EMBL studentship (2012) Honors for MSc and BSc degrees from Università di Napoli Federico II Throughout his career at Microsoft Research, Insitro, and Helmholtz Munich, Casale has led research teams developing computational approaches at the intersection of human genetics and machine learning. His work contributes to landmark projects including the 1000 Genomes Project and Blueprint initiative, with conference presentations at major venues including NeurIPS, ASHG, and EASL. Current grant support likely stems from Helmholtz Association funding mechanisms and collaborative biomedical research programs. He directs the Systems Genetics and Machine Learning Research team at Helmholtz Munich, which operates within the Biomedical Center ecosystem of LMU Munich. The team focuses on leveraging large-scale genetic datasets with machine learning to understand disease biology, with particular emphasis on target identification and characterization for therapeutic development. Current research directions include multi-timepoint omics analysis, disease subtyping, and developing interpretable models for clinical translation.

• Cancer research
• Paediatric malignancies
• Acute lymphoblastic leukaemia
• +۶ مورد دیگر

Associate Professor Daniel Catchpoole is a distinguished researcher in paediatric oncology at the University of Sydney's Faculty of Medicine and Health, specializing in Paediatrics & Child Health. He serves as the Head of the Tumour Bank at The Children's Hospital at Westmead, a position he has held since 2001, and is a founding member of the Australian Biospecimens Network. As an Associate Professor, he lectures on Molecular Biology of Development at Sydney University and serves as President of the International Society for Biological and Environmental Repositories (2020-2021). Dr. Catchpoole holds a BAppSc in Biomedical Science and a PhD from UNSW (1995). With over 20 years of full-time laboratory research experience, his career has focused on the molecular basis of paediatric malignancies, particularly acute lymphoblastic leukaemia and neuroblastoma, as well as cancer-prone syndromes in children like Beckwith Wiedemann syndrome. His research spans multiple disciplines within cancer biology, with particular emphasis on bioinformatics, molecular biology, and translational approaches to paediatric malignancies. Dr. Catchpoole has established microarray technology within the Children's Cancer Research Unit at Westmead and has extensive experience with gene expression analysis. His work bridges cellular and molecular approaches with clinical applications, focusing on improving outcomes for children with cancer through advanced genomic and bioinformatic techniques. Analysis of his recent publications reveals a strong focus on biobanking infrastructure, cancer genomics, neuroblastoma research, and computational approaches to omics data. His work demonstrates increasing integration of machine learning techniques with traditional molecular biology approaches, particularly in the analysis of neuroblastoma and other childhood cancers. The research shows a clear trajectory toward more sophisticated genomic analysis methods and their application to clinical problems in paediatric oncology. President of International Society for Biological and Environmental Repositories (2020-2021) Founding member of Australian Biospecimens Network Active participant in Australasia's Biospecimens Network Association Dr. Catchpoole has secured multiple significant research grants including NHMRC equipment grants for the Fluidigm BioMark HD system (2012) and the Ion Torrent Personal Genome Machine (2010), as well as Cancer Institute NSW grants for high-throughput virtual microscopy systems and research on systems biology for personalized medicine of childhood leukaemia. His work with the Tumour Bank has been instrumental in supporting childhood cancer research across multiple institutions. As Head of the Tumour Bank at The Children's Hospital at Westmead, Dr. Catchpoole leads a critical infrastructure for pediatric cancer research in Australia. His work establishing microarray technology within the Children's Cancer Research Unit has created a foundation for advanced genomic analysis of pediatric malignancies. The biobanking initiatives he has developed support multiple research teams investigating childhood cancers, providing essential resources for translational research from bench to bedside.

• biostatistics
• medical informatics
• rheumatology
• +۴ مورد دیگر

Dr. Necdet SÜT serves as the Institute Director of Health Sciences and Department Head of Biostatistics and Medical Informatics at Trakya University Faculty of Medicine since 2008. He contributes to clinical research ethics, editorial leadership of Balkan Medical Journal, and national vaccination policy analysis. Current roles: Institute Director, Faculty Board Member, Clinical Research Ethics Committee Former roles: Deputy Director of Health Sciences Institute, Rectorate Measurement Unit President His research focuses on biostatistical modeling in clinical medicine, particularly rheumatology, diabetes, breast cancer survival analysis, and vaccine hesitancy during the pandemic. He has published extensively on COVID-19 vaccination responses in immunocompromised populations, mental health during pandemics , and medical imaging applications in oncology. Recent publications analyze biostatistical methods in vaccine efficacy studies, genetic polymorphisms in chronic disease, and medical informatics in diagnostic classification systems. Despite extensive collaboration networks, specific student mentees are not detailed in the text.

Janna Hastingsمشاهده پروفایل

استادیار

• Medical Knowledge Systems
• Artificial Intelligence in Healthcare
• Ontology Development
• +۴ مورد دیگر

Janna Hastings is Assistant Professor for Medical Knowledge and Decision Support at the Institute for Implementation Science in Health Care (Faculty of Medicine) at the University of Zurich since August 2022, while also serving as Vice-Director of the School of Medicine at the University of St. Gallen. Her research focuses on digitalization in clinical contexts, examining how AI-driven knowledge systems reshape clinical practice, professional identity, and doctor-patient relationships. Education: PhD in Computational Biology (University of Cambridge, 2019), part-time MSc in Computer Science (University of South Africa, 2011), MSc in Philosophy (Open University, 2012) Prior Roles: Group Coordinator at European Bioinformatics Institute (2006-2015), Postdoctoral Researcher at Otto-von-Guericke University Magdeburg (2019-2022), Co-Leader of Human Behaviour-Change Project at University College London (2017-2022) Her research spans ontology development for biomedical domains (ChEBI, Human Behaviour Ontology), AI applications in healthcare decision-making, and behavior change interventions. Key projects include: Building ChEBI molecular ontology Developing Human Behaviour-Change Project knowledge system Ontology-driven mental health frameworks LLM applications in radiation oncology Time-series modeling of metabolism in ageing She explores the capabilities and limitations of clinical AI systems, with publications in JMIR and Lancet Digital Health , covering topics like bias prevention in generative AI and proteomic biomarker discovery. Her work bridges biomedical research with implementation science and digital ethics.

Melissa J. Spencerمشاهده پروفایل

استاد

• Muscular Dystrophy
• Gene Therapy
• CRISPR
• +۴ مورد دیگر

Melissa J. Spencer is a Professor in the Department of Neurology at the University of California Los Angeles (UCLA) School of Medicine. Her research focuses on muscular dystrophies , particularly Duchenne muscular dystrophy (DMD) and limb girdle muscular dystrophies (LGMDs) , with an emphasis on gene therapy , CRISPR applications , and immune modulation in therapeutic contexts. Principal Investigator on multiple NIH grants including R01NS117912 (2020-2025) for AAV vector optimization Co-Principal Investigator on NIH RC1AR058333 (2009-2011) for exon skipping research Research Trends in her recent publications span: Gene Delivery Systems (AAV, nanoparticles, CRISPR strategies) Immune Response Analysis in gene therapy recipients Muscle Fibrosis mechanisms and macrophage polarization Therapeutic Development for LGMD and DMD Her work integrates molecular biology , genomics , and clinical applications to address degenerative muscle conditions.

• Genetics
• Cell Biology
• Pharmacogenetics
• +۳ مورد دیگر

Renee Geck is an Assistant Professor of Biology at Gonzaga University, specializing in genetics and cellular biology. She holds a Ph.D. from Harvard University's Biological and Biomedical Sciences program and a B.S. from George Fox University. Her research focuses on yeast genetics, pharmacogenetics, and experimental evolution, particularly studying how genetic variations impact drug responses and cellular adaptation. She integrates her research with education through initiatives like the yEvo Lab, providing high school students with authentic research experiences. Geck's work bridges basic science and clinical applications, collaborating with organizations like ClinGen to improve genetic variant interpretation. Her research spans two core areas: using yeast models to assess human genetic variants' functional impacts and studying evolutionary adaptations in yeast under stress conditions. She emphasizes interdisciplinary approaches, combining computational biology, experimental evolution, and outreach to foster scientific literacy and community engagement. Her teaching portfolio includes courses on genetics, molecular biology, and biological systems, reflecting her commitment to equipping students with critical thinking skills. Geck actively involves undergraduates in her research, emphasizing hands-on learning and ethical scientific practice. She also contributes to advancing cancer biology research, exploring mechanisms of therapeutic resistance and cellular signaling pathways.

Jason Parkمشاهده پروفایل

استاد

• Genomics
• Laboratory Medicine
• Pediatric Gastrointestinal Pathology
• +۵ مورد دیگر

Jason Park is a Professor in the Department of Pathology at UT Southwestern Medical Center, specializing in genomics, laboratory medicine, and pediatric gastrointestinal pathology. He serves as Chief of the Division of Genomic and Molecular Pathology and directs the Advanced Diagnostics Laboratory at Children’s Medical Center Dallas and the Molecular Diagnostics Laboratory at UT Southwestern. His research focuses on molecular diagnostics, cancer therapeutics, and nanotechnology, with 14 US patents to his name. Dr. Park holds editorial leadership as Editor-in-Chief of Clinical Chemistry . Education : BS/MD from Pennsylvania State University/Jefferson Medical College, MD/PhD through Thomas Jefferson University’s Gibbon Scholar program. Pathology residency and chief residency at the University of Pennsylvania, followed by a gastrointestinal and liver pathology fellowship at Johns Hopkins Hospital. Certified in Clinical Chemistry (molecular diagnostics) and Anatomic/ Clinical Pathology by the American Board of Pathology. Research Interests : Integrates genomic and molecular approaches to address challenges in diagnostics, particularly in pediatric gastrointestinal disorders and cancer. Active in translational research for immune-related adverse events in cancer immunotherapy and metabolic therapies for genetic disorders like Glut1 deficiency. His work bridges laboratory innovation with clinical practice, emphasizing precision medicine and diagnostic accuracy. Publications & Recognition : Over 250 peer-reviewed articles, book chapters, and abstracts. Notable contributions include studies on immune-checkpoint inhibitors, SARS-CoV-2 variant detection, and re-evaluation of genomic test results. Media engagements include features in the New York Times and Reuters. Honors include Fellow of the College of American Pathologists (FCAP). Grants & Leadership : Leads research initiatives in genomic reinterpretation and molecular diagnostics. Advocates for improved healthcare workforce data and laboratory transparency through publications and surveys on pathologist job markets and Medicare payment trends. Labs/Teams : Oversees cutting-edge facilities including the Advanced Diagnostics Lab (Children’s Medical Center) and Molecular Diagnostics Lab (UT Southwestern), fostering innovation in genomic testing and clinical pathology.

Baiba Vilneمشاهده پروفایل

پژوهشگر

• Bioinformatics
• Genomics
• Cardiovascular Genetics
• +۵ مورد دیگر

Baiba Vilne serves as PhD Laboratory Manager and Bioinformatics Group Curriculum Validation and Validation Coordination Expert at Rīga Stradiņš University, where she holds a significant research position supervising PhD students and leading major genomic research initiatives. Her ORCID profile (0000-0002-1084-7067) documents extensive scholarly activity with 44 research outputs, 13 active or completed projects, and 5 datasets. Her research expertise spans bioinformatics, genomics, and cardiovascular genetics, with particular focus on coronary artery disease, hematopoiesis, and exome sequencing applications. Vilne's work bridges computational biology with clinical applications, analyzing genetic variants through genome-wide association studies and mitochondrial DNA analysis to understand disease mechanisms. Her research contributes to UN Sustainable Development Goals related to good health and well-being. Dr. Vilne's recent publications demonstrate sophisticated analytical approaches to complex genomic datasets, with notable work on mitochondrial DNA variants in coronary artery disease, CDC42 targeting in skeletal degeneration, and genetic factors in cervical insufficiency. Her research methodology emphasizes FAIR data principles and computational reproducibility. She currently serves as Expert for the Latvian Council of Science in Biological Sciences (2022-2025) and leads multiple significant projects including: HiCALS: Hypothalamic mechanisms of High-Calorie intervention in ALS (Partner's coordinator) DC4MND: Multidimensional mechanistic investigations in motor neuron disease (Partner's coordinator) Towards Improving Coronary Artery Disease Risk Prediction (Supervisor) Clonal hematopoiesis research in cardiovascular diseases (Leading expert) Dr. Vilne actively participates in academic knowledge sharing through conference organization (including 'Genetic Variants Classification' workshops in 2024) and serves as an expert in international research consortia such as the EXPOSE project on metabolic adaptations in aging.

• Genetic Epidemiology
• Cancer Disparities
• Population Genetics
• +۳ مورد دیگر

Christopher Haiman , ScD, is a Professor of Preventive Medicine at the Keck School of Medicine of the University of Southern California (USC), where he serves as the AFLAC Chair in Cancer Research and Director of the Center for Genetic Epidemiology. His work focuses on unraveling racial and ethnic disparities in cancer risk , particularly through genome-wide association studies (GWAS) and large-scale genomic consortia in minority populations. Leadership Roles: Cancer Epidemiology Program (USC Norris Comprehensive Cancer Center), Division Chief of Epidemiology and Genetics Key Research Areas: Genetic epidemiology, polygenic risk scores, social determinants of health, and gene-environment interactions Dr. Haiman co-leads the Multiethnic Cohort (MEC) , a prospective study of cancer in non-European ancestry populations (n>215,000), and directs the African Ancestry Prostate Cancer Consortium (AAPC). His team has published over 450 peer-reviewed papers in journals like Nature Genetics and The New England Journal of Medicine , highlighting his expertise in integrating multi-omics data to identify novel cancer susceptibility genes. Scientific Awards: AFLAC Chair in Cancer Research Notable Contributions: Development of ancestry-specific polygenic risk models, discovery of novel prostate cancer loci in African and Latino populations, and characterization of germline variants in DNA repair genes. His interdisciplinary approach combines genetic epidemiology , social determinants , and clinical applications to address cancer disparities.

• Head and Neck Cancer
• Thyroid Pathology
• Endocrine System Diseases
• +۵ مورد دیگر

Manju Prasad, MD, MBBS, is a Professor of Pathology and Director of Endocrine, Head & Neck Pathology at Yale School of Medicine. She specializes in oncologic pathology of head and neck cancers, including thyroid, parathyroid, and salivary gland tumors. Her research focuses on molecular mechanisms underlying endocrine cancers and improving diagnostic approaches through genetic and immunohistochemical analyses. Education & Training: Fellowship: Memorial Sloan Kettering Cancer Center (2000) Fellowship: Memorial Sloan Kettering Cancer Center (1999) Residency: New York Presbyterian Hospital (1998) MD: Institute of Medical Sciences, Varanasi (1984) MBBS: Institute of Medical Sciences, Varanasi (1981) Research Interests: Dr. Prasad’s work spans thyroid carcinoma molecular profiling, head/neck melanoma in UV-protected sites, HPV-associated head/neck cancers, and public education on endocrine tumors. She leads an ACGME-accredited Endocrine & Head & Neck Pathology Fellowship program. Key Contributions: Developed diagnostic frameworks for thyroid nodules with genetic fusions (e.g., THADA-IGF2BP3) and non-V600E BRAF mutations. Advanced global consensus on NIFTP classification through multi-institutional studies. Pioneered single-cell analysis of parathyroid tissue to understand transcriptional dynamics. Awards: 2023: Yale Cancer Center Award for Excellence in Clinical Care Labs/Teams: Directs the Endocrine & Head & Neck Pathology division, collaborating with molecular and cytopathology teams. Active in the Endocrine Cancers Program and Head and Neck SPORE initiatives.